Shao Yan, General Manager

Graduated from Peking University School of Pharmaceutical Sciences
• For 20 years, Ms. Shao has led and participated in pharmaceutical R & D,biochemical and immune technology R & D and clinical technology in pharmaceutical field; has led and participated in pharmaceutical R & D, industrial transformation and patent registration and application of dozens of new drugs, sustained-release and controlled-release preparations and injections;
• Lead and participated in the development and market transformation of several biochemical and immune technology related kits;
• Rich experience in project management and enterprise management, as well as pharmaceutical product marketing experience. She has worked in famous pharmaceutical enterprises or R & D companies at home and abroad, such as Venturepharma, Livzon pharmaceutical, Sangon Biotech (Shanghai).

Peter Xue, Deputy General Manager

Graduated from the clinical major of Shaanxi University of Chinese medical
• 20-year involvement in medical research and development, and management; led and got involved in clinical trials and registration application of over ten new drugs;
• Once served in medical research institutes; was responsible for institute/hospital subject management; attended “1035 project” management of the Ministry of Science and Technology;
• Got involved in the establishment, research and development and clinical trial of multiple new drug projects in research institutes and pharmaceutical enterprises;
• Had worked in a domestic Sino-foreign funded CRO company held management position; got involved in the clinical trial and registration of multiple new drugs.

Gao Hongzhi, Expert of Data Management and Statistics

Main Leader of the Clinical Pharmacology Department of 307 Hospital
• Graduated from the biostatistics major of Second Military Medical University, over 30 years of experience till now;
• Published more than 20 statistical articles on clinical studies of human pharmacokinetics in Chinese pharmacology journal, Chinese pharmacology bulletin, and Chinese New Pharmaceutical Journal.
• Relying on 307 Hospital platform, He has completed a number of research and statistical work on minocycline, norcantharidin, levodropropizine, voriconazole and artemisinin drugs (06Z071) funded by the army's "Eleventh Five Year Plan" command project.

Certification & Honors

Certification & Honors

Certification & Honors

Certification & Honors

Medical Affairs

Noahpharm owns a group of high-quality clinical experts and a well-trained medical team, and enjoys a good reputation for acquiring the high-quality clinical trial data and meeting customers’ expectations on clinical development. Different from counterparts, we take into account products of different customers, design protocols using technologies such as bridging or exemption based on clinical quantitative pharmacology, and formulate for customers the practical and feasible clinical development strategy, which could greatly shorten the drug clinical development time and further cut clinical fee. Besides, we can independently design and conduct the clinical trial protocol for mass balance study.

Clinical Operation

Noahpharm provides customers with all-round clinical operation services covering from the early clinical trial to final approval for marketing of the drug. We are not only responsible for the sponsor, but also assume the same commitment for the patient, doctor, investigator and regulator. While establishing the team for your study, we will refer to our clinical experience and professional treatment knowledge, and ensure to provide the exactly solution for you.

Data Management & Statistical Analysis

Noahpharm can meet the customer’s specific data management and statistical analysis demand during the trial, and provide the customer with flexible and precise solutions through the whole process from study startup to the end of study, covering biostatistical services in all aspects of clinical development.